Pope, Janet

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., et al. (2015) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesInflammatory mediators and NSAID effects

Cited by 907

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Khanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2016) · The Lancet

Systemic Sclerosis and Related DiseasesRheumatoid Arthritis Research and Therapies

Cited by 683

A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure

Pope, J. E. (1993) · Archives of Internal Medicine

Blood Pressure and Hypertension StudiesInflammatory mediators and NSAID effects

Cited by 527

C-reactive protein and implications in rheumatoid arthritis and associated comorbidities

Pope, J. E., & Choy, E. H. (2021) · Seminars in Arthritis and Rheumatism

Rheumatoid Arthritis Research and TherapiesBiomarkers in Disease Mechanisms

Cited by 320

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

Khanna, D., Denton, C. P., Lin, C. J. F., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2018) · Annals of the Rheumatic Diseases

Systemic Sclerosis and Related DiseasesConnective tissue disorders research

Cited by 265

Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis

Widdifield, J., Bernatsky, S., Paterson, J. M., Gunraj, N., Thorne, J. C., Pope, J., Cividino, A., & Bombardier, C. (2013) · Arthritis Care & Research

Rheumatoid Arthritis Research and TherapiesOrthopedic Infections and Treatments

Cited by 219

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update

Mancini, G. B. J., Tashakkor, A. Y., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D. S., et al. (2013) · Canadian Journal of Cardiology

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 173

Management of fatigue in rheumatoid arthritis

Pope, J. E. (2020) · RMD Open

Rheumatoid Arthritis Research and TherapiesMusculoskeletal pain and rehabilitation

Cited by 137

Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center

Pope, J., McBain, D., Petrlich, L., Watson, S., Vanderhoek, L., de Leon, F., Seney, S., & Summers, K. (2011) · Arthritis & Rheumatism

Systemic Sclerosis and Related DiseasesConnective tissue disorders research

Cited by 124

Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors

Baker, K., Pope, J., Fortin, P., Silverman, E., Peschken, C., & 1000 Faces of Lupus Investigators and CaNIOS (Canadian Network for Improved Outcomes in SLE) (2009) · Lupus

Systemic Lupus Erythematosus ResearchRetirement, Disability, and Employment

Cited by 78